Ive previously reviewed the GLP-1 family of peptides extensively (here and here) and it seems every week there is a new potential use case, such as we recently saw for migraine and the oneAlzheimers disease that we await with a very high level of anticipation in September from the 2 large trials with semaglutide
This was demonstrated by a sixty percent reduction in mortality risk when compared to the placebo therefore subsequent trials to determine whether or not CNM-Au8 could provide neuroprotective advantages in ALS and other neuro-degenerative disorders are urgently required ( CNM-Au8, nanocrystals were also tested on patients of relapsing-remitting multiple sclerosis (RRMS), non-active secondary progressive multiple sclerosis (SPMS), or primary progressive multiple sclerosis (PPMS) in an investigator-initiated, open-label, expanded-access study (NCT04081714) for evaluating the safety, pharmacokinetics (PK), and pharmacodynamics
Copper peptides are often recommended after non-invasive skin procedures such as laser resurfacing, dermabrasion, chemical peels, and micro-needling
Joint issues Joint problems involving multiple tissue types often benefit from the wolverine stack's comprehensive approach